Advertisement
Screener

VivoSim Labs, Inc. (VIVS) Form ARS: Annual report to security holders

VivoSim Labs, Inc. Form ARS: Annual report to security holders

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2026-08-21: Form ARS; Period of report 2026-03-31; Description ARS; Document d134973dars.pdf.
  • 2025-11-06: Form ARS; Period of report 2025-03-31; Description ARS; Document vivs_ars20250331.pdf.
  • 2024-10-07: Form ARS; Period of report 2024-03-31; Description ARS; Document onvo_ars_2024_0331.pdf.
  • 2023-09-13: Form ARS; Period of report 2023-03-31; Description ARS; Document onvo_ars_2023_0331.pdf.
FiledFormPeriod of reportDescriptionDocument
2026-08-21ARS2026-03-31ARSd134973dars.pdf
2025-11-06ARS2025-03-31ARSvivs_ars20250331.pdf
2024-10-07ARS2024-03-31ARSonvo_ars_2024_0331.pdf
2023-09-13ARS2023-03-31ARSonvo_ars_2023_0331.pdf

Similar stocks

Stock NameCountryMarket CapPE Ratio
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
Silexion Therapeutics Corp (SLXN)$0.001B
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70